Next Article in Journal
Restraint Stress Alters Expression of Glucocorticoid Bioavailability Mediators, Suppresses Nrf2, and Promotes Oxidative Stress in Liver Tissue
Next Article in Special Issue
The Cutaneous Physiological Redox: Essential to Maintain but Difficult to Define
Previous Article in Journal
Synthetic vs. Natural Hydroxytyrosol for Clean Label Lamb Burgers
Previous Article in Special Issue
Polyphenols by Generating H2O2, Affect Cell Redox Signaling, Inhibit PTPs and Activate Nrf2 Axis for Adaptation and Cell Surviving: In Vitro, In Vivo and Human Health
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 9
Issue 9
10.3390/antiox9090852
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Commentary

Oxidative Stress: Concept and Some Practical Aspects

by
Helmut Sies
1,2
1
Institute of Biochemistry and Molecular Biology I, Heinrich-Heine-University Düsseldorf, University Street 1, Bldg 22.04, D-40225 Düsseldorf, Germany
2
Leibniz Research Institute for Environmental Medicine, Heinrich-Heine-University Düsseldorf, D-40225 Düsseldorf, Germany
Antioxidants 2020, 9(9), 852; https://doi.org/10.3390/antiox9090852
Submission received: 21 August 2020 / Revised: 2 September 2020 / Accepted: 8 September 2020 / Published: 10 September 2020
(This article belongs to the Special Issue Oxidative Stress, Classification and Quantitation)
Browse Figures
Review Reports Versions Notes

Abstract

:
Oxidative stress is defined as “an imbalance between oxidants and antioxidants in favor of the oxidants, leading to a disruption of redox signaling and control and/or molecular damage”. This Commentary presents basic features of this global concept which has attracted interest in biology and medicine. The term “antioxidants” in cellular defense against oxidants predominantly includes antioxidant enzymes with their substrates and coenzymes. Exogenous low-molecular-mass compounds also have a role, but this is more limited. Multiple biomarkers of damage due to oxidative stress have been identified for different molecular classes (protein, lipid, carbohydrate, and DNA), and the current state of practical aspects in health and disease is delineated.

1. Introduction

“Oxidative stress” is a global concept in redox biology and medicine. Since its introduction in 1985 [1], it has attracted widespread interest and also some critical comments [2], and it is covered in detail in a textbook [3] (pp. 199–283). The literature on oxidative stress is voluminous, and comprehensive coverage is not the subject of this Commentary; for example, the active fields of oxidative stress research in microbes and in plants are not covered, but the general principles apply to these fields as well. Rather, an attempt will be made to address the current state of knowledge in terms of practical aspects. Due to the multitude of oxidant and antioxidant processes occurring simultaneously in normal and pathophysiological conditions in different cells and organs, there have been numerous endeavors of translational application in a wide range of health and disease situations. Some of these have been based on oversimplifications. I will address this issue with some examples, focusing on recent literature.

2. Oxidative Stress

A brief survey of the literature in the Web of Science gives over 450,000 hits for the term “oxidative stress”, with about 40,000 new additions in 2020. Unsurprisingly, a comprehensive view on the current development of this term would be challenging.

2.1. The Concept of Oxidative Stress

The global concept of “Oxidative Stress” is defined as “an imbalance between oxidants and antioxidants in favor of the oxidants, leading to a disruption of redox signaling and control and/or molecular damage” [4,5]. It has developed from its initial formulation in 1985 [1] to incorporate new knowledge on the role of redox signaling [2]. The basic idea is that, in the open metabolic system, a steady-state redox balance is maintained at a given setpoint, which provides a basal redox tone, and that a deviation from the steady-state redox balance is considered a stress, initiating a stress response. Implicit in the definition of oxidative stress is (i) that a deviation to the opposite side of the balance is “reductive stress”, and (ii) that there are physiological deviations, “oxidative eustress”, and supraphysiological deviations, “oxidative distress” [5]. Oxidative eustress is an essential part of redox control and physiological redox signaling [6,7] (Figure 1). This concept overlaps with that of redox homeostasis as the “golden mean” [8]. Current knowledge on these topics has been presented in the book, “Oxidative stress: eustress and distress” [9].

2.2. Oxidative Stress: A Slice of the Pie

The molecular mechanisms of metabolic regulation include a multitude of chemical means. Structure and functions are implemented by orchestrated chemical modification of proteins, lipids, carbohydrates, and, not-the-least, nucleic acids. Redox reactions contribute to regulation, and it is noteworthy that there is crosstalk between different modes of regulation, e.g., between redox modifications and phosphorylation/dephosphorylation of proteins. Chemically reactive molecules of low-molecular-mass (“reactive species”) have been extensively investigated in their role in regulation. Recent accounts were given for reactive oxygen species (ROS) [7], reactive nitrogen species (RNS) [10,11], reactive sulfur species (RSS) [12], reactive electrophile species (RES) [13], and reactive halogen species (RHS) [14]. Clearly, multiple interactions constitute checks and balances in redox regulation [15].

3. Antioxidants

On the other side of the redox balance, the defense against damaging levels of oxidants consists of several types of antioxidant enzymes in conjunction with their back-up systems, as well as of low-molecular-mass antioxidants, forming an antioxidant network [16]. The complement of antioxidant enzymes is subject to regulation by redox master switches as part of the oxidative stress response (see Ref. [5] for a review). While these two preceding sentences appear to be uncontested, a widespread misconception about “antioxidants” and “antioxidant capacity” deserves a comment [17,18,19]. In lay language, the term antioxidant seems to be confined solely to exogenous low-molecular-mass compounds, neglecting the much more important contribution of antioxidant enzymes (with their substrates and coenzymes) to cellular defense against oxidants. This misconception also pervades in the scientific community, best exemplified by the term “antioxidant capacity”, or even “total antioxidant capacity (TAC)”. The misconception can be traced back to the work of excellent organic chemists, who investigated the capability of isolated human blood plasma to trap artificially generated peroxyl radicals [20]. This was the origin of the term “total antioxidant capacity” which, while true for isolated plasma in vitro, unfortunately is a misnomer as it was subsequently applied to the in vivo situation by many investigators. Such tests (TRAP, FRAP, ORAC, ABTS) do not assay any antioxidant enzyme capacity, and a more appropriate name instead of TAC would have been NEAC, non-enzymatic antioxidant capacity [21].
In their textbook, Halliwell and Gutteridge devoted a chapter to antioxidants synthesized in vivo [3] (pp. 77–152) and a separate one on antioxidants from the diet [3] (pp. 153–198), emphasizing the points made above: “Antioxidant is a term widely used but surprisingly difficult to define clearly”, and the simplified definition is “any substance that delays, prevents or removes oxidative damage to a target molecule” [3] (p. 77). Hopefully, the distinction between endogenous and exogenous antioxidants will guide more prudent research in the future.

4. Practical Aspects

Against this background, it is obvious that oxidative stress will have different intensities [22] and manifestations in different cell types and organs, as discussed previously [5,7,23]. The set of principles which defines the spatiotemporal positioning of the biological redox systems has been described as the “redox code” [24]. Redox patterns across cells and within subcellular spaces resemble a dynamic “landscape” rather than being flat [7,15,24].

4.1. Biomarkers

In accordance with the variety of compounds and pathways, numerous biomarkers of oxidative stress have been identified [25]. Frijhoff et al. [26] examined the relevance of specific biomarkers of oxidative stress in various diseases, as depicted in a cluster analysis (Figure 2).
Obviously, measuring a single biomarker is not clinically useful [27]. The epistemological challenges of using such biomarkers have been discussed [28]. Ghezzi [29] proposed a classification of biomarkers of oxidative stress (Table 1), which may help guide researchers in the field. A specific term worth pursuing further is “actionability of oxidative stress biomarkers”, i.e., whether a given biomarker is causally involved in the disease or not [29]. Advances in technology provide further opportunities for biomarkers, e.g., in redox phospholipidomics [30], proteomics [31], amino acids [32], protein lipoxidation [33], or metabolomics [34]. Gender- and age-dependencies of different oxidative stress biomarkers have been noted [35].

4.2. Clinical Aspects

There is a wide literature of oxidative stress manifestation in clinical settings, as presented in pertinent reviews [5,7,23,36,37,38,39]. In-depth discussion of these aspects is beyond the scope of this Commentary (see [40]). A promising emerging area for research relates to mind-body medicine [41], the relationship between psychological stress and oxidative stress [42,43]. Our recent coverage on oxidative stress manifestation in clinical settings [7] is on the following topics: central nervous system; immune system, inflammation and wound repair; cardiovascular system; skeletal muscle; insulin sensitivity and pathogenesis of diabetes; ROS in aging and lifespan regulation; cancer; and prospects for redox medicine. Redox systems analysis of antioxidant networks will help to further understand the interplay of nutrition and oxidative stress [44].

5. Conclusions

Understanding the mechanisms of maintenance of the redox balance has progressed in recent time, opening opportunities for redox-based strategies in practical applications in medicine (“redox medicine”). Due to the complexity of interlinked stress response systems, future research will focus on redox systems biology.

Funding

This research received no external funding.

Acknowledgments

Fruitful discussions with Wilhelm Stahl are gratefully acknowledged.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Sies, H. (Ed.) Oxidative stress: Introductory remarks. In Oxidative Stress; Academic Press: London, UK, 1985; pp. 1–8. [Google Scholar]
  2. Sies, H. On the history of oxidative stress: Concept and some aspects of current development. Curr. Opin. Toxicol. 2018, 7, 122–126. [Google Scholar] [CrossRef]
  3. Halliwell, B.; Gutteridge, J.M.C. Free Radicals in Biology and Medicine; Oxford University Press: Oxford, UK, 2015. [Google Scholar]
  4. Sies, H.; Jones, D.P. Oxidative stress. In Encyclopedia of Stress, 2nd ed.; Fink, G., Ed.; Elsevier: Amsterdam, The Netherlands, 2007; Volume 3, pp. 45–48. [Google Scholar]
  5. Sies, H.; Berndt, C.; Jones, D.P. Oxidative stress. Annu. Rev. Biochem. 2017, 86, 715–748. [Google Scholar] [CrossRef] [PubMed]
  6. Sies, H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress. Redox. Biol. 2017, 11, 613–619. [Google Scholar] [CrossRef] [PubMed]
  7. Sies, H.; Jones, D.P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 2020, 21, 363–383. [Google Scholar] [CrossRef] [PubMed]
  8. Ursini, F.; Maiorino, M.; Forman, H.J. Redox homeostasis: The Golden Mean of healthy living. Redox. Biol. 2016, 8, 205–215. [Google Scholar] [CrossRef]
  9. Sies, H. (Ed.) Oxidative Stress: Eustress and Distress; Academic Press: London, UK, 2020; pp. 1–844. [Google Scholar]
  10. Möller, M.N.; Rios, N.; Trujillo, M.; Radi, R.; Denicola, A.; Alvarez, B. Detection and quantification of nitric oxide-derived oxidants in biological systems. J. Biol. Chem. 2019, 294, 14776–14802. [Google Scholar] [CrossRef] [Green Version]
  11. Nakamura, T.; Lipton, S.A. Nitric oxide-dependent protein post-translational modifications impair mitochondrial function and metabolism to contribute to neurodegenerative diseases. Antioxid. Redox Signal. 2020, 32, 817–833. [Google Scholar] [CrossRef]
  12. Olson, K.R. Reactive oxygen species or reactive sulfur species: Why we should consider the latter. J. Exp. Biol. 2020, 223, jeb196352. [Google Scholar] [CrossRef]
  13. Parvez, S.; Long, M.J.C.; Poganik, J.R.; Aye, Y. Redox signaling by reactive electrophiles and oxidants. Chem. Rev. 2018, 118, 8798–8888. [Google Scholar] [CrossRef]
  14. Davies, M.J.; Hawkins, C.L. The role of myeloperoxidase in biomolecule modification, chronic inflammation, and disease. Antioxid. Redox Signal. 2020, 32, 957–981. [Google Scholar] [CrossRef] [Green Version]
  15. Santolini, J.; Wootton, S.A.; Jackson, A.A.; Feelisch, M. The redox architecture of physiological function. Curr. Opin. Physiol. 2019, 9, 34–47. [Google Scholar] [CrossRef] [PubMed]
  16. Sies, H. Strategies of antioxidant defense. Eur. J. Biochem. 1993, 215, 213–219. [Google Scholar] [CrossRef] [PubMed]
  17. Pinchuk, I.; Shoval, H.; Dotan, Y.; Lichtenberg, D. Evaluation of antioxidants: Scope, limitations and relevance of assays. Chem. Phys. Lipids. 2012, 165, 638–647. [Google Scholar] [CrossRef] [PubMed]
  18. Pompella, A.; Sies, H.; Wacker, R.; Brouns, F.; Grune, T.; Biesalski, H.K.; Frank, J. The use of total antioxidant capacity as surrogate marker for food quality and its effect on health is to be discouraged. Nutrition 2014, 30, 791–793. [Google Scholar] [CrossRef]
  19. Sies, H. Total antioxidant capacity: Appraisal of a concept. J. Nutr. 2007, 137, 1493–1495. [Google Scholar] [CrossRef] [PubMed]
  20. Wayner, D.D.; Burton, G.W.; Ingold, K.U.; Locke, S. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett. 1985, 187, 33–37. [Google Scholar] [CrossRef]
  21. Bartosz, G. Non-enzymatic antioxidant capacity assays: Limitations of use in biomedicine. Free Radic. Res. 2010, 44, 711–720. [Google Scholar] [CrossRef]
  22. Lushchak, V.I. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem. Biol. Interact. 2014, 224C, 164–175. [Google Scholar] [CrossRef]
  23. Egea, J.; Fabregat, I.; Frapart, Y.M.; Ghezzi, P.; Görlach, A.; Kietzmann, T.; Kubaichuk, K.; Knaus, U.G.; Lopez, M.G.; Olaso-Gonzales, G.; et al. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox. Biol. 2017, 13, 94–162. [Google Scholar] [CrossRef] [Green Version]
  24. Jones, D.P.; Sies, H. The redox code. Antioxid. Redox Signal. 2015, 23, 734–746. [Google Scholar] [CrossRef] [Green Version]
  25. Griffiths, H.R.; Møller, L.; Bartosz, G.; Bast, A.; Bertoni-Freddari, C.; Collins, A.; Cooke, M.; Coolen, S.; Haenen, G.; Hoberg, A.-M.; et al. Biomarkers. Mol. Aspects Med. 2002, 23, 101–208. [Google Scholar] [CrossRef]
  26. Frijhoff, J.; Winyard, P.G.; Zarkovic, N.; Davies, S.S.; Stocker, R.; Cheng, D.; Knight, A.R.; Taylor, E.L.; Oettrich, J.; Ruskovska, T.; et al. Clinical relevance of biomarkers of oxidative stress. Antioxid. Redox Signal. 2015, 23, 1144–1170. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Lichtenberg, D.; Pinchuk, I.; Weber, D. Oxidative stress, as assayed by a single test, cannot be used as a diagnostic tool. Biofactors 2018, 44, 222–223. [Google Scholar] [CrossRef] [PubMed]
  28. Ghezzi, P.; Ghiara, V.; Davies, K. Epistemological challenges of the oxidative stress theory of disease and the problem of biomarkers. In Oxidative Stress: Eustress and Distress; Sies, H., Ed.; Academic Press: London, UK, 2020; pp. 13–27. [Google Scholar]
  29. Ghezzi, P. Environmental risk factors and their footprints in vivo—A proposal for the classification of oxidative stress biomarkers. Redox Biol. 2020, 34, 101442. [Google Scholar] [CrossRef] [PubMed]
  30. Kagan, V.E.; Tyurina, Y.Y.; Sun, W.Y.; Vlasova, I.I.; Dar, H.; Tyurin, V.A.; Amoscato, A.A.; Mallampalli, R.; van der Wel, P.C.A.; He, R.R.; et al. Redox phospholipidomics of enzymatically generated oxygenated phospholipids as specific signals of programmed cell death. Free Radic. Biol. Med. 2020, 147, 231–241. [Google Scholar] [CrossRef] [PubMed]
  31. Liu, X.; Long, M.J.C.; Aye, Y. Proteomics and beyond: Cell decision-making shaped by reactive electrophiles. Trends Biochem. Sci. 2019, 44, 75–89. [Google Scholar] [CrossRef]
  32. Gamon, L.F.; Guo, C.; He, J.; Hägglund, P.; Hawkins, C.L.; Davies, M.J. Absolute quantitative analysis of intact and oxidized amino acids by LC-MS without prior derivatization. Redox Biol. 2020, 36, 101586. [Google Scholar] [CrossRef]
  33. Patinen, T.; Adinolfi, S.; Cortés, C.C.; Härkönen, J.; Deen, A.J.; Levonen, A.L. Regulation of stress signaling pathways by protein lipoxidation. Redox Biol. 2019, 23, 101114. [Google Scholar] [CrossRef]
  34. Liu, K.H.; Nellis, M.; Uppal, K.; Ma, C.; Tran, V.; Liang, Y.; Walker, D.I.; Jones, D.P. Reference Standardization for quantification and harmonization of large-scale metabolomics. Anal. Chem. 2020, 92, 8836–8844. [Google Scholar] [CrossRef]
  35. Pinchuk, I.; Weber, D.; Kochlik, B.; Stuetz, W.; Toussaint, O.; Debacq-Chainiaux, F.; Dolle, M.E.T.; Jansen, E.H.J.M.; Gonos, E.S.; Sikora, E.; et al. Gender- and age-dependencies of oxidative stress, as detected based on the steady state concentrations of different biomarkers in the MARK-AGE study. Redox Biol. 2019, 24, 101204. [Google Scholar] [CrossRef]
  36. Hayes, J.D.; Dinkova-Kostova, A.T.; Tew, K.D. Oxidative stress in cancer. Cancer Cell 2020, 38, 167–197. [Google Scholar] [CrossRef] [PubMed]
  37. Kim, S.Y.; Park, C.; Jang, H.J.; Kim, B.O.; Bae, H.W.; Chung, I.Y.; Kim, E.S.; Cho, Y.-H. Antibacterial strategies inspired by the oxidative stress and response networks. J. Microbiol. 2019, 57, 203–212. [Google Scholar] [CrossRef] [PubMed]
  38. Sbodio, J.I.; Snyder, S.H.; Paul, B.D. Redox mechanisms in neurodegeneration: From disease outcomes to therapeutic opportunities. Antioxid. Redox Signal. 2019, 30, 1450–1499. [Google Scholar] [CrossRef]
  39. Vassalle, C.; Maltinti, M.; Sabatino, L. Targeting oxidative stress for disease prevention and therapy: Where do we stand, and where do we go from here. Molecules 2020, 25, 2653. [Google Scholar] [CrossRef]
  40. Casas, A.I.; Dao, V.T.; Daiber, A.; Maghzal, G.J.; di Lisa, F.; Kaludercic, N.; Leach, S.; Cuadrado, A.; Jaquet, V.; Seredenina, T.; et al. Reactive oxygen-related diseases: Therapeutic targets and emerging clinical indications. Antioxid. Redox Signal. 2015, 23, 1171–1185. [Google Scholar] [CrossRef] [Green Version]
  41. Aschbacher, K.; Mason, A.E. Eustress, distress and oxidative stress: Promising pathways for mind-body medicine. In Oxidative Stress: Eustress and Distress; Sies, H., Ed.; Academic Press: London, UK, 2020; pp. 583–617. [Google Scholar]
  42. Aschbacher, K.; O’Donovan, A.; Wolkowitz, O.M.; Dhabhar, F.S.; Su, Y.; Epel, E. Good stress, bad stress and oxidative stress: Insights from anticipatory cortisol reactivity. Psychoneuroendocrinology 2013, 38, 1698–1708. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Siegrist, J.; Sies, H. Disturbed redox homeostasis in oxidative stress: A molecular link from chronic psychosocial work stress to coronary heart disease? Circ. Res. 2017, 121, 103–105. [Google Scholar] [CrossRef]
  44. Dennis, K.K.; Go, Y.M.; Jones, D.P. Redox systems biology of nutrition and oxidative stress. J. Nutr. 2020, 149, 553–565. [Google Scholar] [CrossRef]
Antioxidants 09 00852 g001 550
Figure 1. Oxidative stress and its relationship to redox signaling. Physiological (low) oxidant exposure addresses specific (highly-reactive) targets, whereas supraphysiological (high) exposure addresses unspecific targets. Adaptive responses counteract. Further important oxidants are generated in secondary reactions; e.g., ONOOH, from O2·− and ·NO, or HOCl, from H2O2 and Cl−. Modified from Ref. [6]. Creative Commons License.
Figure 1. Oxidative stress and its relationship to redox signaling. Physiological (low) oxidant exposure addresses specific (highly-reactive) targets, whereas supraphysiological (high) exposure addresses unspecific targets. Adaptive responses counteract. Further important oxidants are generated in secondary reactions; e.g., ONOOH, from O2·− and ·NO, or HOCl, from H2O2 and Cl−. Modified from Ref. [6]. Creative Commons License.
Antioxidants 09 00852 g001
Antioxidants 09 00852 g002 550
Figure 2. Clinical relevance of biomarkers of oxidative stress. Color coding on right: Protein (green), lipid (blue), and DNA (red) biomarkers are analyzed for various diseases. Color coding on top: results from cluster analysis. Data compiled from Frijhoff et al. [26], presented as Figure 11 in Ref. [5], with permission.
Figure 2. Clinical relevance of biomarkers of oxidative stress. Color coding on right: Protein (green), lipid (blue), and DNA (red) biomarkers are analyzed for various diseases. Color coding on top: results from cluster analysis. Data compiled from Frijhoff et al. [26], presented as Figure 11 in Ref. [5], with permission.
Antioxidants 09 00852 g002
Table
Table 1. Classification of biomarkers related to oxidative stress. Compiled from Ghezzi [29].
Table 1. Classification of biomarkers related to oxidative stress. Compiled from Ghezzi [29].
TypeBiomarker
Type 0Direct measurement of specific ROS molecule (e.g., H2O2)
Type 1Protein carbonyls; MDA, HNE, isoprostanes, oxLDL; 8-oxo-dG
Type 2HOCl; uric acid, allantoin
Type 3SOD, CAT, GPX, PON1, NOX, XO, DUOX, Vit. E, Vit. C, bilirubin; [note: caveat on “TAC” Refs. [18,19]
Type 4Genetic factors and mutations

Share and Cite

MDPI and ACS Style

Sies, H. Oxidative Stress: Concept and Some Practical Aspects. Antioxidants 2020, 9, 852. https://doi.org/10.3390/antiox9090852

AMA Style

Sies H. Oxidative Stress: Concept and Some Practical Aspects. Antioxidants. 2020; 9(9):852. https://doi.org/10.3390/antiox9090852

Chicago/Turabian Style

Sies, Helmut. 2020. "Oxidative Stress: Concept and Some Practical Aspects" Antioxidants 9, no. 9: 852. https://doi.org/10.3390/antiox9090852

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop